Martin Shkreli, 32, is finally getting his day in court, and for those looking for a reason to continue to loathe this guy, it didn’t disappoint.
Although he is facing federal securities fraud, and is known as the man who thought it was a wise business decision to spike a life-saving drug that helped fight HIV from $13.50 to $750 per pill, his bravado entered the Congressional chambers before he did.
And he hardly said a word.
Committee Chairman Jason Chaffetz, a Utah Republican, asked Shkreli what he would tell a single, pregnant woman with AIDS who needed Daraprim to survive, and whether he thought he had done anything wrong.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in